Please note: To view the design of this website, you need a browser that supports web standards. The content of this site is accessible (with no formatting) to any browser. Upgrade to a Web standards compliant browser.
Skip to the content of this page

Jules Traeger, MD

Synopsis: Traeger J, Galland R, Delawari E, Arkouche W, Hadden R. Six years' experience with short daily hemodialysis: do the early improvements persist in the mid and long term? Hemodialysis International 2004;8(2):151-158.

Observational studies from several groups have shown consistent beneficial effects in patients treated with short daily hemodialysis (SDHD). The cardiovascular and nutritional changes appear during the first few months after the initiation of SDHD. An extensive review of 17 patients from a group of 36 ESRD patients treated for up to 6 years with SDHD was undertaken to compare the clinicobiologic results during the initial period of standard hemodialysis (3 x 4 hr/week) and the short daily hemodialysis period at 1 year (SDHD1) and subsequent years (SDHD2). The statistical analysis of the clinicobiologic data clearly shows that the initial favorable results obtained during the first year of SDHD do persist in the mid and long term, which shows the more physiologic nature of this dialytic approach. The amelioration of left ventricular hypertrophy is of particular interest, showing a regression of ventricular dilation during the first year followed by a reduction of interventricular septum and posterior wall thickness during the subsequent years.

Commentary by Todd S. Ing, MD

Dr. Traeger and his colleagues have demonstrated that the early benefits observed with a short "daily" hemodialysis regimen (6 sessions per week, 120-150 minutes per session) will persist up to 6 years (the period of follow-up up to the time of writing). These favorable results do lend support to the notion that this variety of high-intensity dialytic therapy may turn out to be a treatment of choice.

Disclaimer: These abstracts are only intended for the dissemination of scientific knowledge and for the intellectual exchanges of innovative ideas among healthcare workers. Although the innovative articles we select for inclusion in our Innovative Papers section have all appeared in prestigious publications, not all the avant-garde ideas conveyed in these articles have been accepted into standard medical practice. Patients should obtain advice related to their medical care from their own healthcare providers, and not from information provided by our Innovative Papers section. Clinicians must make informed decisions with regard to the care of their patients. Information obtained from ISHD is for the purposes of general medical education only and should not be misconstrued as medical advice. Neither ISHD nor the information contributors are responsible for any possible injury sustained by patients who are treated by clinicians who mistakenly use information conveyed anywhere on this site for therapeutic purposes.

Copyright ©2010 International Society for Hemodialysis. All rights reserved.